ArticleMedicine2026
The combined impact of inflammation and oxidative balance on mortality risk in rheumatoid arthritis patients: A retrospective cohort study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oxidative stress and systemic inflammation play pivotal roles in rheumatoid arthritis (RA) progression. However, the combined impact of oxidative balance and inflammatory status on mortality risk in RA patients remains insufficiently investigated. This study aimed to explore these potential associations. We analyzed data from 24,552 participants in the National Health and Nutrition Examination Survey (NHANES, 2007-2018). Oxidative balance was assessed using the oxidative balance score (OBS), while inflammatory status was evaluated via the systemic inflammation response index (SIRI). Cox proportional-hazards models, Kaplan-Meier survival curves, and mediation analysis were employed to examine independent and joint associations. After adjusting for confounders, each 1-point increase in the OBS was associated with a 4 % reduction in mortality (HR = 0.96, 95 % CI 0.92-1.00, P = .047), and participants in the high OBS group exhibited a 37 % lower mortality risk than those with low OBS (HR = 0.63, 95 % CI 0.42-0.94, P = .023). Whereas every 1-unit rise in the SIRI elevated the risk by 14 % (HR = 1.14, 95 % CI 1.04-1.25, P = .005), and individuals in the high SIRI group faced more than double the risk seen in their low SIRI counterparts (HR = 2.30, 95 % CI 1.18-4.49, P = .014). A potential protective effect of an antioxidant-oriented diet and lifestyle was suggested only in patients with systemic inflammation, although the association did not reach conventional statistical significance (HR = 0.59, 95% CI 0.34-1.01, P = .053). No significant benefit was observed among patients without systemic inflammation. Spearman correlation revealed a weak inverse association between OBS and SIRI (R = -0.095, P = .007). Mediation analysis confirmed that antioxidants attenuate mortality risk in RA patients by reducing inflammatory response, with a mediation proportion of 14.6% (P <.001). Antioxidants exhibit protective effects against inflammation-related mortality in RA patients, suggesting that enhancing oxidative balance may serve as a potential intervention strategy to prevent RA associated deaths.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.